Showing results (101-110 of 4,494) with videos related to

Sort By:
Pageof 450
Advances in Therapy|April 19, 2022
Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and MauritiusArmand Mbanya, Azarkhan Ackbarkhan, Mohammad Yaseen Mittoo, et al.
Advances in Therapy|April 22, 2022
Ixekizumab Citrate-Free Formulation: Results from Two Clinical TrialsSanjay Chabra, B J Gill, Gaia Gallo, et al.
Advances in Therapy|April 25, 2022
Clinicopathologic Characteristics and Prognosis of PDGFRA-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in ChinaPeng Zhang, Ming Wang, Jian Li, et al.
Advances in Therapy|April 29, 2022
17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicenter, Randomized Controlled TrialChengyu Luo, Changsheng Wei, Wenbin Guo, et al.
Advances in Therapy|April 17, 2022
Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL StudyXin Wang, Guangyu Wu, Dan Shen, et al.
Advances in Therapy|October 19, 2021
Cost-Effectiveness Analysis of First-Line Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma in the United StatesWeiting Liao, Wanting Lei, Mingyang Feng, et al.
Advances in Therapy|January 30, 2022
Assessment of the Cost-Effectiveness of HER2-Targeted Treatment Pathways in the Neoadjuvant Treatment of High-Risk HER2-Positive Early-Stage Breast CancerJesse A Sussell, Joshua A Roth, Craig S Meyer, et al.
Advances in Therapy|October 15, 2021
Non-Surgical Treatments for Keratinocyte CarcinomasKylee J B Kus, Emily S Ruiz
Advances in Therapy|October 21, 2021
Outcome of Patients with Locally Advanced Metastatic Medullary Thyroid Cancer and Induction Therapy with Tyrosine Kinase Inhibitors in SloveniaCvetka Grasic Kuhar, Taja Lozar, Nikola Besic, et al.
Advances in Therapy|March 17, 2022
Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study)Bincy Abraham, Bertus Eksteen, Khan Nedd, et al.
Pageof 450